Related Experiment Video
Updated: Apr 13, 2026

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells
Published on: January 20, 2019
EphB1 Suppression in Acute Myelogenous Leukemia: Regulating the DNA Damage Control System
K R Kampen1, F J G Scherpen1, G Garcia-Manero2
1Department of Pediatric Oncology, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Ephrin receptor B1 (EphB1) acts as a tumor suppressor in acute myelogenous leukemia (AML). Loss of EphB1 expression, linked to promoter methylation, impairs DNA damage response and programmed cell death, correlating with poor survival in pediatric AML.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Signaling
Background:
- Ephrin receptor B1 (EphB1) loss is linked to aggressive cancer phenotypes, but its role in acute myelogenous leukemia (AML) is unclear.
- Understanding EphB1's mechanism is crucial for developing targeted AML therapies.
Purpose of the Study:
- To investigate the transcriptional regulation and function of EphB1 in AML.
- To elucidate EphB1's role in the DNA damage response (DDR) pathway in AML.
Main Methods:
- Analysis of EphB1 transcript levels and promoter methylation in AML cell lines.
- Assessing EphB1 reintroduction effects on DDR signaling and cell death.
- Comparing EphB1 expression and methylation in pediatric AML samples versus normal bone marrow.
Main Results:
- EphB1 transcript inversely correlated with promoter methylation in AML cells.
- EphB1 presence restored ligand-mediated p53 binding and DDR cascade activation.
- Reintroducing EphB1 in methylated AML cells enhanced DDR and induced apoptosis.
- Pediatric AML samples showed suppressed EphB1 expression and increased promoter hypermethylation.
- EphB1 repression correlated with poor overall survival in pediatric AML.
Conclusions:
- EphB1 exhibits a tumor-suppressor function in pediatric AML by regulating the DDR.
- EphB1's role in DDR suggests its clinical relevance across various malignancies.
- EphB1 is a key regulator of cancer cell transforming pathways.
Related Concept Videos
Abnormal Proliferation
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Negative Regulator Molecules
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Mitogens and the Cell Cycle

